logo

For the Inventor, By the Inventor

Tabarz, Germany

Olaf Peters

This inventor holds 16 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in Antitumor Compounds. Top assignees: Schering Aktiengesellschaft, Sterix Limited, Bayer Aktiengesellschaft. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olaf Peters. Retrieved from https://idiyas.com/inventor/olaf-peters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 37.5

 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Jena, DE (2003 - 2013)
  • Tabarz, DE (2007 - 2023)

Company Filing History:

goldMedal6 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal5 out of 51 
 
Sterix Limited
 patents
bronzeMedal2 out of 12,269 
 
Bayer Aktiengesellschaft
 patents
4. 2 out of 1,036 
 
Bayer Cropscience Ag
 patents
5. 2 out of 387 
 
Bayer Pharma Aktiengesellschaft
 patents
6. 1 out of 192 
 
Bayer Schering Pharma Ag
 patents
where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Herbicidal Compounds
Benzimidazole Derivatives
Estratrienes
Antitumor Activity
Selective Estrogens
Steroid Inhibitors
Pharmaceutical Compositions
Fertility Regulation
16 patents (USPTO):Explore Patents
1. 11613522 - Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro- and dihydrofurancarboxamides (2023-03-28),
2. 11597724 - Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxylic acids and esters (2023-03-07),
3. 10730856 - Benzimidazole derivatives as EP4 ligands (2020-08-04),
4. 9708311 - Benzimidazole derivatives as EP4 antagonists (2017-07-18),
5. 8492570 - 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action (2013-07-23),
6. 8026229 - Antitumor-active 2-alkoxyestradiol sulfamates (2011-09-27),
7. RE42132 - Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates (2011-02-07),
8. 7732493 - 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2010-06-08),
9. 7435757 - 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2008-10-14),
10. 7427610 - 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action (2008-09-23),
11. 7419972 - 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 (2008-09-02),
12. 7378404 - 8β-hydrocarbyl-substituted estratrienes for use as selective estrogens (2008-05-27),
13. 7375098 - 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes (2008-05-20),
14. 7244762 - Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates (2007-07-17),
15. 6794409 - Use of ER&bgr;-selective ligands for regulating fertility and compounds useful therefor (2004-09-21),

Title: Olaf Peters: Pioneering the Future of Plant Protection

Introduction:

Olaf Peters, a brilliant inventor hailing from Tabarz, Germany, has become a prominent figure in the world of innovation. With a commendable portfolio of 16 patents, Peters stands as a beacon of inspiration for aspiring inventors globally. His relentless pursuit of innovation and commitment to creating a better future for generations to come have solidified his reputation in the field.

Latest Patents:

Among his notable inventions are "Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro- and dihydrofurancarboxamides" and "Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxylic acids and esters." These patents showcase Peters' expertise in the field of plant protection and highlight his innovative approach to addressing agricultural challenges.

Career Highlights:

Olaf Peters has made significant contributions to various companies throughout his career. He has lent his expertise to renowned organizations such as Schering Aktiengesellschaft and Sterix Limited, where his inventive spirit and dedication to innovation have shone through. Peters' passion for creating impactful solutions has driven his success in the industry.

Collaborations:

Throughout his professional journey, Peters has collaborated with esteemed colleagues such as Alexander Hillisch and Christian Gege. These alliances have fostered a dynamic environment for innovative ideas to flourish, leading to groundbreaking inventions in the realm of plant protection and beyond. Peters' ability to collaborate effectively has been instrumental in his inventive pursuits.

Conclusion:

In conclusion, Olaf Peters' remarkable journey as an inventor exemplifies the power of innovation and vision in shaping a better tomorrow. His legacy in the field of plant protection serves as a testament to his unwavering commitment to driving positive change through inventive solutions. Peters' impact on the world of invention is profound, and his contributions continue to inspire future generations of inventors to push the boundaries of what is possible in the realm of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…